Notify me when Pivotal bioVenture Partners Investment Advisor LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 12 | $258,658,319 | +$48,672,788 | -$28,926,679 | +$19,746,109 | PCVX, OCS, ARQT, EVMN, ZBIO | 13F-HR | 13 Feb 2026, 16:04 |
| Q3 2025 | 10 | $172,983,714 | +$9,321,211 | -$23,637,368 | -$14,316,157 | PCVX, OCS, ARQT, ZBIO, TRVI | 13F-HR | 13 Nov 2025, 16:06 |
| Q2 2025 | 12 | $161,342,907 | +$26,549,416 | -$756,587 | +$25,792,829 | OCS, PCVX, ARQT, INZY, ZBIO | 13F-HR | 13 Aug 2025, 16:05 |
| Q1 2025 | 11 | $123,562,016 | +$10,975,918 | $0 | +$10,975,918 | OCS, ARQT, PCVX, ZBIO, INZY | 13F-HR | 14 May 2025, 16:05 |
| Q4 2024 | 11 | $148,065,879 | +$13,131,006 | -$3,760,040 | +$9,370,966 | PCVX, OCS, ARQT, INZY, ZBIO | 13F-HR | 13 Feb 2025, 16:06 |
| Q3 2024 | 11 | $168,472,266 | +$22,723,237 | -$17,800,227 | +$4,923,010 | PCVX, INZY, ARQT, OCS, ZBIO | 13F-HR | 13 Nov 2024, 16:04 |
| Q2 2024 | 10 | $130,066,695 | +$121,830 | -$12,011,368 | -$11,889,538 | PCVX, INZY, OCS, ARQT, EXAI | 13F-HR | 13 Aug 2024, 16:05 |
| Q1 2024 | 11 | $155,581,738 | +$1,169,370 | -$290,863,853 | -$289,694,483 | PCVX, INZY, ARQT, OCS, FUSN | 13F-HR | 14 May 2024, 16:07 |
| Q4 2023 | 13 | $394,215,626 | +$2,599,181 | -$3,705,518 | -$1,106,337 | KRTX, PCVX, OCS, INZY, FUSN | 13F-HR | 13 Feb 2024, 16:06 |
| Q3 2023 | 13 | $250,716,366 | +$11,214,867 | -$1,786,862 | +$9,428,005 | KRTX, PCVX, OCS, INZY, RLYB | 13F-HR | 13 Nov 2023, 16:05 |
| Q2 2023 | 11 | $303,344,814 | +$12,599,466 | -$10,567 | +$12,588,899 | KRTX, PCVX, OCS, INZY, RLYB | 13F-HR | 11 Aug 2023, 16:06 |
| Q1 2023 | 11 | $242,860,084 | +$23,784,487 | -$8 | +$23,784,479 | KRTX, PCVX, INZY, OCS, RLYB | 13F-HR | 12 May 2023, 16:11 |
| Q4 2022 | 10 | $229,952,126 | +$875,998 | -$16,107,850 | -$15,231,852 | KRTX, PCVX, RLYB, ARQT, VIGL | 13F-HR | 13 Feb 2023, 16:05 |
| Q3 2022 | 11 | $273,655,000 | +$6 | -$27,340,674 | -$27,340,668 | KRTX, RLYB, PCVX, AKUS, ARQT | 13F-HR | 10 Nov 2022, 16:09 |
| Q2 2022 | 11 | $185,810,000 | +$3,637,154 | -$6,332,402 | -$2,695,248 | KRTX, PCVX, RLYB, ARQT, AKUS | 13F-HR | 12 Aug 2022, 16:07 |
| Q1 2022 | 11 | $211,350,000 | +$3,941,000 | $0 | +$3,941,000 | KRTX, PCVX, RLYB, FUSN, EXAI | 13F-HR | 13 May 2022, 16:10 |
| Q4 2021 | 10 | $239,161,000 | +$15,260,000 | -$6,992,685 | +$8,267,315 | KRTX, PCVX, RLYB, EXAI, AKUS | 13F-HR | 14 Feb 2022, 09:21 |
| Q3 2021 | 9 | $282,943,000 | +$39,930,016 | $0 | +$39,930,016 | KRTX, RLYB, PCVX, BOLT, AKUS | 13F-HR | 15 Nov 2021, 16:03 |
| Q2 2021 | 8 | $253,722,000 | $0 | -$8,900,444 | -$8,900,444 | KRTX, PCVX, BOLT, INZY, AKUS | 13F-HR | 16 Aug 2021, 16:13 |
| Q1 2021 | 9 | $311,695,000 | +$62,248,000 | -$41,056,503 | +$21,191,497 | KRTX, BOLT, INZY, PCVX, AKUS | 13F-HR | 14 May 2021, 16:07 |
| Q4 2020 | 9 | $303,302,000 | $0 | $0 | $0 | KRTX, PCVX, AKUS, INZY, ALGS | 13F-HR | 09 Feb 2021, 16:50 |